Friday, 6 November 2015

Medcine packaging and Supply chain Industry



The global pharmaceutical sector is embarking on a transformational journey in which the supply chain will play an increasing strategic role. There will be a need for greater agility and improved speed to market, while ensuring compliance with myriad regulatory requirements. This forms a challenging landscape for the global medicine packaging  industry. Consider what happens when supply chains break down: Drugs are delayed to market, customers experience poor service, security and compliance risks heighten, and a host of missed opportunities occur.
So when you are selecting a contract packager to handle your supply chain, there are several factors to consider. One is length of service.Other factors to consider include:


  • Compliance with the FDA, DEA, as well as the MHRA
  • Employment of rigorous QA processes and cGMP quality systems
  • GDUFA Compliance
  • Serialization capabilities and experience
  • Capabilities which include Rest of World (RoW) packaging, Brite stock labeling and F=1 compliant packaging
  • Medicine packaging design services for turn-key production
  • Pharmaceuticals (Rx, OTC, Generic & Private Label), Nutritionals & Supplements, Beauty & Personal Care, Medical Devices, Veterinary Healthcare
  • Small to large batches
  • Cold chain storage & retain storage
It is to be clear you can rely on our increased capacity, our commitment to responsive delivery expectations, and our agility in meeting the custom needs of your business. It is currently met every standard and It will continue to add capacity where needed to meet the unique specifications of our pharmaceutical customers.

Wednesday, 4 November 2015

Types of Medical Packaging Missteps to Avoid

Medical device packaging engineers often face tight deadlines and budgets. So when the members of the Flexible Packaging were brainstorming recently on how to help package engineers, the group decided to focus on how they could help packaging engineers minimize cycle times, iterations, and costs during new package development.

Misstep 1: Missing Some Stakeholders
One of the first missteps discussed in Medicine Packaging is not taking into account stakeholders “There’s a growing emphasis on eliminating all defects in the packaging process, so the challenge is designing a defect-free package that accommodates all Critical to Quality (CTQ) [attributes] while meeting design constraints such as cost and manufacturing,” he said. “Avoiding missteps starts with making sure you include all your stakeholders in the design process. Stakeholders are both internal and external, and they all have their own CTQs that need to be considered.”
One example involves package dimensional tolerances. “We often see specifications that call out dimensional tolerances that may or may not be realistic. “Make sure the specification you are calling out is something that your supplier can actually manufacture. It is an example of including your external stakeholder early in the design process.” Other mistakes involve neglecting critical dimensions.

Misstep 2: Mismeasurements in Heat Sealing
 Mistakes in Medicine Packaging can also be made during heat-sealing processes. There are several misconceptions when it comes to parameter measurements and machine set up. One is assuming “that setting and actual sealing conditions are the same,” he said. For instance, there can be differences between the temperatures of the gauge versus the actual temperature of the platen surface, he said. Also, there can be differences in dwell-time measurements depending upon when the sealer activates the timer—is it when the platen begins to move or when it is closed and pressure begins?

Misstep 3: Misunderstanding Distribution's Effects
 And missteps can also occur when distribution’s influence on package performance isn’t considered. One common misstep is to use a pouch that’s too large for a folding carton, explained Russell Darley, R&D Manager for Sealed Air Medical Applications. “To fit the pouch in the carton, the pouch must be folded several times; we call this creating a compound fold,” he said. “Multiple folds in a material can create material stress points, which during distribution events like vibration, impact, or free-fall drops can result in abrasion, flex cracking, pin holes, and material separation.” Using pouches and cartons that aren’t appropriately matched can be the outcome of programs that use a one-size-fits-all approach to packaging.

As a result, they might not select the appropriate distribution simulation protocol and could see damage in the field, a poor product-to-packaging ratio, or experience other missteps. He offered a few key recommendations on how to better understand such channels. “Spend time out in the field following your distribution channel, map the process, talk to employees, and make observations.

Tuesday, 3 November 2015

Medicine Packaging Innovations



Bilcare Research is a leading full-service provider in the field of medicine packaging. As a global supplier with single-source capabilities, we offer a comprehensive range of pharmaceutical packaging solutions, from product-specific research to brand-building materials and design.

It is our aim to innovate and develop pioneering packaging solutions to meet the complex needs of the pharmaceutical industry. With our integrated services, we enable clients to focus on their core business, i.e. development of new drug molecules, formulation development, manufacturing and marketing while we partner with them in the area of drug stabilization and protection. We help customers capitalize on upcoming trends, through products that maximize the commercial potential and efficacy of drugs.

Our strength lies in the powerful synergy of our research capabilities, state-of-the-art design and manufacturing facilities and commitment to create sustainable competitive advantages for our customers. Our competency in developing specialty medicine packaging material and designs helps customers in addressing compliance and counterfeit concerns.

Today, Bilcare Research is a market-leading supplier of specialty primary packaging for pharmaceutical products. We have been honoured by the Organization of Pharmaceutical Producers of India (OPPI) Award for achieving remarkable success in providing novel packaging alternatives and services to the pharmaceutical sector for two consecutive years.

Sunday, 1 November 2015

Pharma Packaging Challenges


There is a growing focus in the medicine Packaging industry on producing environmentally sustainable products. Increasingly consumers, and by extension retailers, are demanding the items they purchase have as little impact on the environment as possible. In fact, 71% 71 percent of people are influenced to purchase paper and packaging products based on sustainable attributes, according to a recent survey by Asia Pulp and Paper (APP). Pharmaceutical Packaging challenges 
Traditionally, pharmaceutical companies were more concerned about manufacturing and supplying costs than about eco-friendliness, but with the growing pharmaceutical market, companies are now expected to be more transparent in business practices, including the downstream role they play in impacting the environment. Ultimately this means packaging is sourced and made from more sustainable materials—with the goal of less packaging in general.



Utilizing sustainable medicine packaging can be a challenge for everyday packaging needs, but even more so in the pharmaceutical industry where government safety regulations and patient usability take precedence. While consumers and retailers are shifting to a more environmentally conscious mindset, they still expect pharma companies to adhere to safety regulations and manufacture high-quality packaging for their products.

Although challenges still exist in the medicine packaging production, innovation will continue to provide solutions for more efficient packaging and a cleaner environment. According to Bilcare, Research planning and development departments and engineers will all play a key role in the future of pharma packaging. Pharma companies will benefit from the time spent transitioning to a more sustainable model, especially as they see growing consumer satisfaction.